𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The incidence of lymphoma in first-degree relatives of patients with Hodgkin disease and non-Hodgkin lymphoma : Results and limitations of a registry-linked study

✍ Scribed by Ora Paltiel; Tal Schmit; Bella Adler; Eliezer A. Rachmilevitz; Aaron Polliack; Amos Cohen; Nissim Haim; Menachem Ben Shachar; Ron Epelbaum; Micha Barchana; Ronit Cohen; Dina Ben Yehuda


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
104 KB
Volume
88
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

The precise incidence of familial hodgkin disease (hd) and non-hodgkin lymphoma (nhl) in first-degree relatives is unknown. through record linkage using two population-based sources, the authors estimated the risk of hd and nhl in family members of lymphoma probands.

Methods:

The authors identified 8,037 first-degree relatives of 2,606 lymphoma cases (28.5% hd, 71.5% nhl) treated between 1970 and 1993 in 3 hospitals in israel via the family file of the population registry. the authors linked this file with the israel cancer registry, then calculated the standardized incidence ratio (sir) by dividing the observed number of cases with the expected, adjusting for age, gender, calendar year, and continent of origin.

Results:

The family file yielded incomplete ascertainment of relatives (for 771 probands, no relatives were identified). twenty cases of lymphoma--6 hd and 14 nhl--were identified among relatives of lymphoma patients. the sir for hd was 1.15 (95% confidence interval [ci]: 0.42-2.51) and for nhl 1.71 (95% ci: 0.93-2.87), considering the entire population of first-degree relatives. sirs among siblings of lymphoma probands were 3.12 (95% ci: 1.01-7.29) for hd, 2.16 (95% ci: 0.45-6.31) for nhl, and 2.68 (95% ci: 1.15-5.27) for all lymphomas. there were 4 hd/hd, 1 nhl/nhl, and 3 nhl/hd sibling pairs. for hd/hd and nhl/nhl sibling pairs, the interval between lymphoma occurrence in proband and sibling was 1-4 years, whereas for hd/nhl pairs this ranged from 16 to 21 years.

Conclusions:

The risk of lymphoma among siblings of lymphoma probands was over 2.5-fold that of the general population and lower among other family members. the temporal proximity of hd/hd and nhl/nhl sibling pairs argues for environmental as well as genetic etiology. this method was hampered by incomplete data.


πŸ“œ SIMILAR VOLUMES


Application of the international prognos
✍ Tony S. Mok; Joyce Steinberg; Anthony T. Chan; Winnie M. Yeo; P. Hui; Thomas W. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 193 KB πŸ‘ 1 views

## Background: Chemotherapy containing anthracycline is the standard initial treatment for aggressive non-hodgkin's lymphoma (nhl), and the international prognostic index (ipi) is widely accepted as the standard tool for determining the prognosis of patients with this disease. however, the data on

CEOP treatment results and validity of t
✍ C. S. Chim; Y. L. Kwong; A. K. W. Lie; C. K. Lee; R. Liang πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 1 views

From 1991 to 1997, we have treated 78 newly diagnosed patients with aggressive non-Hodgkin's lymphoma with a modified CHOP regimen in which epirubicin (60 mg/m 2 ) was used in place of doxorubicin (50 mg/m 2 ), i.e. CEOP (cyclophosphamide, epirubicin, vincristine and prednisolone). The median age wa

The effect of in vitro irradiation on mi
✍ Samuel Rotstein; Edward Baral; Henric Blomgren; Bo Johansson πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 381 KB πŸ‘ 2 views

Blood lymphocytes from 20 untreated patients with Hodgkin's disease were compared with those of 20 untreated patients with non-Hodgkin's lymphoma with regard to the responsiveness of the cells to PHA and ConA following exposure to varying doses of ionizing radiation in vitro. Lymphocytes from 19 of

A randomized comparison of the efficacy
✍ Reena Nair; Gopal Ramakrishnan; Narendran N. Nair; Tapan K. Saikia; Purvish M. P πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 2 views

## BACKGROUND. Combination chemotherapy consisting of methotrexate, doxorubicin, cyclophosphamide, vincristine, prednisolone, and bleomycin (MACOP-B) has been frequently used for the treatment of non-Hodgkin's lymphoma. This randomized study was undertaken to assess the efficacy and toxicity of th